Gilead Sciences is laying off 108 employees from Arcellx's Redwood City site. This action follows Gilead's recent $7.8 billion acquisition of CAR-T biotech Arcellx. The job cuts are part of the integration process after the buyout closed. Affected employees have been notified of the decision. The layoffs are scheduled to begin at the end of June.
Redwood City, CA
https://www.fiercebiotech.com/biotech/after-arcellx-buyout-close-gilead-trims-108-jobs-car-t-biotechs-redwood-city-outpost